NASDAQ:SINT

Sintx Technologies (SINT) Stock Price, News & Analysis

$0.15
+0.10 (+180.36%)
(As of 01:58 PM ET)
Today's Range
$0.10
$0.19
50-Day Range
$0.02
$0.14
52-Week Range
$0.02
$1.82
Volume
695.62 million shs
Average Volume
31.52 million shs
Market Capitalization
$3.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SINT stock logo

About Sintx Technologies Stock (NASDAQ:SINT)

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

SINT Stock Price History

SINT Stock News Headlines

Sintx Technologies Prices Public Offering Of $1.3 Mln Of Shares
Why Is Sintx Technologies (SINT) Stock Down 31% Today?
Dow Dips 200 Points; Nike Shares Fall After Q3 Results
Sintx Technologies just downgraded at Maxim, here's why
See More Headlines
Receive SINT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sintx Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/27/2024
Today
5/15/2024
Next Earnings (Estimated)
8/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SINT
Fax
N/A
Employees
43
Year Founded
N/A

Profitability

Net Income
$-8,260,000.00
Net Margins
-314.39%
Pretax Margin
-314.39%

Debt

Sales & Book Value

Annual Sales
$2.63 million
Book Value
$1.65 per share

Miscellaneous

Free Float
22,501,000
Market Cap
$1.25 million
Optionable
Not Optionable
Beta
1.39
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. B. Sonny Bal J.D. (Age 62)
    M.B.A., M.D., Ph.D., CEO, President, Principal Financial Officer & Chairman
    Comp: $460.81k
  • Mr. David Francis O'Brien (Age 59)
    Executive VP & COO
    Comp: $432.46k
  • Mr. Michael Marcroft
    Vice President of Sales & Marketing
  • Ms. Gina Moss
    Director of Operations

SINT Stock Analysis - Frequently Asked Questions

Should I buy or sell Sintx Technologies stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sintx Technologies in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SINT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SINT, but not buy additional shares or sell existing shares.
View SINT analyst ratings
or view top-rated stocks.

How have SINT shares performed in 2024?

Sintx Technologies' stock was trading at $0.3814 at the start of the year. Since then, SINT stock has decreased by 66.2% and is now trading at $0.1290.
View the best growth stocks for 2024 here
.

When is Sintx Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024.
View our SINT earnings forecast
.

How were Sintx Technologies' earnings last quarter?

Sintx Technologies, Inc. (NASDAQ:SINT) posted its quarterly earnings results on Wednesday, March, 27th. The company reported ($0.09) EPS for the quarter. The firm earned $0.90 million during the quarter. Sintx Technologies had a negative trailing twelve-month return on equity of 79.81% and a negative net margin of 318.99%.

When did Sintx Technologies' stock split?

Shares of Sintx Technologies reverse split on the morning of Monday, December 19th 2022. The 1-100 reverse split was announced on Monday, December 19th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 19th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

What other stocks do shareholders of Sintx Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sintx Technologies investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Heat Biologics (HTBX), iBio (IBIO), T2 Biosystems (TTOO), AIM ImmunoTech (AIM), Aytu BioPharma (AYTU), Blink Charging (BLNK), Bionano Genomics (BNGO) and Nuwellis (CHFS).

Who are Sintx Technologies' major shareholders?

Sintx Technologies' stock is owned by a variety of institutional and retail investors. Top institutional investors include Anson Funds Management LP (4.23%).
View institutional ownership trends
.

How do I buy shares of Sintx Technologies?

Shares of SINT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SINT) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners